Accurate de novo design of hyperstable constrained peptides

By G. Bhardwaj, Vikram Khipple Mulligan, Christopher D. Bahl, Jason M. Gilmore, P. Harvey, O. Cheneval, G. W. Buchko, S. Pulavarti, Q. Kaas, A. Eletsky and 17 more. 2016

389 citations recorded by the source corpus.

Naturally occurring, pharmacologically active peptides constrained with covalent crosslinks generally have shapes that have evolved to fit precisely into binding pockets on their targets. Such peptides can have excellent pharmaceutical properties, combining the stability and tissue penetration of small-molecule drugs with the specificity of much larger protein therapeutics. The ability to design constrained peptides with precisely specified tertiary structures would enable the design of shape-complementary inhibitors of arbitrary targets. Here we describe the development of computational methods for accurate de novo design of conformationally restricted peptides, and the use of these methods to design 18–47 residue, disulfide-crosslinked peptides, a subset of which are heterochiral and/or N–C backbone-cyclized. Both genetically encodable and non-canonical peptides are exceptionally stable to thermal and chemical denaturation, and 12 experimentally determined X-ray and NMR structures are nearly identical to the computational design models. The computational design methods and stable scaffolds presented here provide the basis for development of a new generation of peptide-based drugs.

Subfields: Microbiology, Molecular Biology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Microbiology

  1. David Baker
  2. William F. DeGrado

In Molecular Biology

  1. David Baker
  2. Jeffrey J. Gray
  3. Tanja Kortemme
  4. Xingjie Pan
  5. Jens Meiler
  6. Po-Ssu Huang
  7. Rhiju Das
  8. Brian D. Weitzner

Citations in the corpus